Supporting Our Clients Against MA Plans’ 340B Inequities
Providers are being ignored by contracted and non-contracted MA plans in their efforts to obtain a remedy for 340B drug underpayments. … Read More
Providers are being ignored by contracted and non-contracted MA plans in their efforts to obtain a remedy for 340B drug underpayments. … Read More
A new corporate whistleblower program incentivizes reporting of healthcare fraud involving private insurance plans. … Read More
Many bills have been pending in state legislatures. Let’s take a look at what’s been recently enacted in three of those states. … Read More
State legislatures have already been busy this year. Here are some topics and bills Ensemble experts have been watching closely. … Read More
Health plans will be required to meet a prior authorization time frame as short as 72 hours, along with providing reasoning for any denials. … Read More
See how Ensemble is actually applying AI to drive value across the entire revenue cycle. … Read More
Federal agencies are scrutinizing Medicare Advantage coding with inaccurate diagnoses for enrollees with certain high-risk diagnoses. … Read More
The 2024 Medicare Advantage Final Rule clarifies that Medicare Advantage (MA) plans must follow the Two-Midnight Rule set in 2013, and more. … Read More
A report from the OIG found some MCOs have unusually high rates of prior authorization denials, with limited or no state oversight. … Read More
This new rule introduces several key changes that will promote transparency and consistency in healthcare coverage decisions. … Read More
Get Our Monthly Newsletter
Stay ahead of the curve with unique perspectives, updates and actionable insights about the revenue cycle issues at the top of your agenda. Delivered monthly.